SMTC

SMTC Total Assets

$1.65BQuarterly · USD

Period ending:

SMTC FY Total AssetsUSD
SMTC FY Total Assets1986-01-31: $7.60M1987-01-31: $10.00M1988-01-31: $12.50M1989-01-31: $14.50M1990-01-31: $15.30M1991-01-31: $17.20M1992-01-31: $16.20M1993-01-31: $15.50M1994-01-31: $16.70M1995-01-31: $19.00M1996-01-31: $32.69M1997-01-31: $41.65M1998-01-31: $67.14M1999-01-31: $92.56M2000-01-31: $149.35M2001-01-31: $677.29M2002-01-31: $690.40M2003-01-31: $620.55M2004-01-31: $408.47M2005-01-31: $457.93M2006-01-31: $473.77M2007-01-31: $521.65M2008-01-31: $396.05M2009-01-31: $420.80M2010-01-31: $514.29M2011-01-31: $659.94M2012-01-31: $726.32M2013-01-31: $1.17B2014-01-31: $948.94M2015-01-31: $929.43M2016-01-31: $911.52M2017-01-31: $1.01B2018-01-31: $1.09B2019-01-31: $1.06B2020-01-31: $1.05B2021-01-31: $1.08B2022-01-31: $1.13B2023-01-31: $2.57B2024-01-31: $1.37B2025-01-31: $1.42B2026-01-25: $1.41B$2.57B$0.00
1986-01-312026-01-25

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SMTC total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 41 observations from Jan 31, 1986 to Jan 25, 2026.

Semtech Corp Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
1,410,337,000
1,419,264,000
1,373,735,000
2,569,628,000
1,130,911,000
1,082,102,000
1,051,748,000
1,062,881,000
1,085,776,000
1,014,130,000
911,517,000
929,431,000
948,940,000
1,171,013,000
726,321,000
659,943,000
514,294,000
420,795,000
396,046,000
521,654,000
473,765,000
457,925,000
408,473,000
620,546,000
690,401,000
677,288,000
149,350,000
92,556,000
67,135,000
41,645,000
32,685,000
19,000,000
16,700,000
15,500,000
16,200,000
17,200,000
15,300,000
14,500,000
12,500,000
10,000,000
7,600,000

Compare total assets

All SMTC financial metrics · SMTC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.